use of pro-kinetics, length of hospital stay and 30-days readmission to the hospital for pain or other US-TAP-block related complications RESULTS: A total of 100 patients who underwent RARP were eligible for the analysis; 57 received the US-TAP block with 20 ml of 0.35% Ropivacaine (US-TAP-block group) and 43 did not receive US-TAP block (no-US-TAP group). All the patients received the local wound anaesthetic infiltration with 20 ml of 0.35% Ropivacaine. US-TAP block group showed a decreased mean NRS (2.7vs1.8; p[0.04) and reduced use of opioid (8 vs 2; p[0.01) in the first 24 h. Moreover, we found a shorter mean LOS (4.7 vs 4.2; p[ 0.04) with a reduced use of pro-kinetics during the hospital stay (31 vs 12; p<0.001). No US-TAP-block related complications to were reported.
INTRODUCTION AND OBJECTIVES:
In the United States, there are more than 115 deaths per day from an overdose of opioids. Previous studies from the US have reported that approximately 5% of opioid-ïve surgical patients become chronic opioid users after a single prescription postoperatively. The aim of our study was to examine the risk of chronic opioid use following radical prostatectomy (RP) in a different health care system. METHODS: We assessed filled prescriptions for opioids in 25,703 men in Prostate Cancer data Base Sweden (PCBaSe)[1] who had undergone retropubic or robot-assisted RP in [2007] [2008] [2009] [2010] [2011] [2012] [2013] [2014] [2015] [2016] [2017] [2018] . Opioid use was examined in three time periods: preoperative (13 months to 1 month before RP), perioperative (1 month before and 1 month after RP), and postoperative (1 to 12 months after RP). Multivariable logistic regression was used to assess the risk of transition to chronic opioid use, defined as one or more opioid prescription(s) in three consecutive months more than two months after surgery.
RESULTS: The median age at RP was 64 years and 86% of men had a Charlson comorbidity index of 0. A total of 1.9% of men had filled an opioid prescription in the preoperative period, followed by a spike in the perioperative period (59%), which sharply decreased in the second month. In the postoperative period, the percentage of men who had filled an opioid prescription was 2.3% (i.e 0.4% higher than in the preoperative period). Among chronic late users, 43% were new users. Unmarried status, low educational level, retropubic RP, high comorbidity, and more advanced risk category were predictors of transition to chronic use of opioids.
CONCLUSIONS: Slightly more than half of Swedish men received opioid prescriptions surrounding radical prostatectomy. The absolute number of patients who became chronic opioid users after surgery was low. Socioeconomic status, comorbidity, cancer characteristics, and surgical approach were all associated with risk of becoming a new chronic user after radical prostatectomy. In former studies, suprapubic tube placement after radical prostatectomy has been shown to be equivalent to a transurethral catheterization concerning complication rates and stricture rates with potential benefits regarding patients' comfort. This prospective randomized trial elucidates the perioperative and long-term functional outcomes depending on type and duration of catheterization after robot-assisted radical prostatectomy.
METHODS: 198 patients were randomized prospectively (May 2016-June 2017): a transurethral catheter was placed in the control group with micturition on postoperative day (POD) 5 (A), while a suprapubic tube (SPT) was used in group B and C. In B, micturition was allowed on POD 5, in C on POD 2. To investigate patient comfort, numeric rating scale for movement and rest was used and usage of pain medication. Functional outcomes were evaluated with a 12-hour Pad test, residual volume analysis on POD 5 (A, B) and POD 2 (C), usage of pads after 4 weeks and up to 12 months and IPSS.
RESULTS: After drop-out of 11 patients, no statistically significant differences could be found in patients' characteristics, perioperative or tumor-related data. Median overall bother was comparable for periods of movement (NRS for A: 2.4; B: 2.1; C: 2.2; p[0.39) and for rest (NRS for A: 1.4; B: 1.4; C: 1.2; p[0.80) with similar intake of pain medication, p[0.07. No differences could be observed in catheter related complications (p[0.86) and prolonged catheterization time occurred in six patients (A: 3; B: 1; C: 2; p[0.61). Median residual urine volume after removal of the catheter was 17 ml for A, 7 ml for B and 11 ml for C (p[0.07). A significantly better continence was observed for group C with 14 ml vs. 30 ml (A) and 24 ml (B) in the 12-hour PAD test on the day of catheter removal, p[0.007. After four weeks, 63% of the patients in C were continent (defined as use of no pad/day) compared to 33% in A and 41% in B, p[0.004. After 12 months, 76% patients were continent in A, 87% in B and 94% in C, p[0.023.
CONCLUSIONS: Suprapubic tube placement instead of transurethral catheterization in robot-assisted radical prostatectomy can beINTRODUCTION AND OBJECTIVES: Goals of radical prostatectomy include complete tumor resection, optimization of urinary function, and maintenance of erectile function. In this Surgical Report card (SuRep) study, we aimed to closely monitor cancer, urinary, and sexual outcomes and provide surgeons with report cards assessing their performance.
METHODS: Prospective radical prostatectomy patients at The Ottawa Hospital were consented for participation in SuRep. All 8 prostate cancer surgeons at The Ottawa Hospital also consented to participation. Feasibility goals for the study were 95% patient enrollment, with 80% participation at 6-months follow-up, and 70% participation at 12-months. At enrollment and follow-up, patient reported outcomes were assessed using validated questionnaires (EPIC and EQ-5D). Patients were defined as potent if they had no erectile dysfunction and continent if they had no incontinence. The patient data was analyzed and report cards were provided to surgeons every 3 months starting approximately 1 year after the first patient was enrolled.
RESULTS: During the study period, 422 of 436 (97%) radical prostatectomy patients participated in the study. Follow-up data was available for 358 (85%) patients at 6-months and 356 (84%) patients at 12-months following surgery. Two-hundred and ten (50%) patients were included in the first year (pre-report card) and 212 (50%) patients were included in the second year (post-report card). Baseline characteristics were similar in the pre-and post-report card cohorts. Almost all patients were continent (98%) and the majority were potent (61%) prior to surgery. Nerve sparing surgery increased from 148 (70%) pre-report card to 173 (82%) post-report card. There was a non-statistically significant increase in the proportion of patients with a positive surgical margin post-report cards (32% pre-report card vs 39% post-report card; p[0.09). There was no difference in postoperative erectile function (24% vs 26%; p[0.69) and a decrease in continence (76% vs 63.2%; p[0.01).
CONCLUSIONS: A surgical report card program including patient reported outcomes is feasible. The data was used to accurately counsel patients about their expected outcomes following radical prostatectomy. With one year of surgical report cards, overall patient outcomes did not improve. We believe that specific initiatives and longer duration of feedback are needed for positive change to occur. (PCa) . Patients with IR PCa on systematic biopsy (SB) have been shown to be at increased risks of adverse pathology (AP) at the time of radical prostatectomy (RP) as compared to lower risk patients. This often leads to reluctance from both urologists and patients in choosing AS as a treatment strategy. This study sought to determine the rate of AP of patients with Gleason Score (GS) 3þ4 on targeted biopsy (TB) and any associated imaging, biopsy, or clinical factors.
METHODS: A retrospective review was conducted of all patients with Gleason Score 3þ4 PCa found on TB who elected treatment with RP. All patients underwent TB of a demonstrable lesion after multiparametric magnetic resonance imaging (mpMRI) as well as SB. These patients then elected for radical prostatectomy. Multivariable logistic regression was then performed of imaging, SB and TB results, and patient characteristics to determine factors associated with AP as defined by either GS > 3þ4, pathologic stage ! T3 disease, or positive lymph nodes.
RESULTS: A total of 121 were found to have Gleason 3þ4 on TB and then elected for RP. Of these patients, 30 (24.8%) were found to have AP after RP consisting of 22 with extraprostatic extension, 11 with GS > 3þ4, 3 with seminal vesicle invasion and one with lymph node positive disease. After multivariable logistic regression, factors associated with AP were age (HR 1.13 95% CI 1.03-1.23, p[0.01) and the highest percentage of targeted core positive for PCa (HR 11.9 95% CI 1. 45-98.05, p[0.02) . A subset analysis was performed of only those with highly suspicious mpMRI lesions based on an in-house scoring system and significant factors after multivariable logistic regression were PSA (HR 1.42 95% CI 1.04-1.94, p[0.03) and the size of the mpMRI lesion p[0.04) CONCLUSIONS: Nearly 25% of patients with GS 3þ4 on TB had AP at the time of RP. Older age and a higher percentage of the TB biopsy core with cancer were associated with AP. Surprisingly, with highly suspicious lesions, smaller lesions were more likely to yield AP which may be due to the difficulty in accurately sampling these lesions. These results may help select appropriate candidates for AS with GS 3þ4 PCa after mpMRI and TB.
